2026 -- H 7936 | |
======== | |
LC005897 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2026 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- PUBLIC HEALTH DATA PRIVACY AND | |
PROTECTION ACT | |
| |
Introduced By: Representatives Donovan, Furtado, Ajello, Dawson, Boylan, Roberts, | |
Date Introduced: February 27, 2026 | |
Referred To: House Health & Human Services | |
(Dept. of Health) | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Title 23 of the General Laws entitled "HEALTH AND SAFETY" is hereby |
2 | amended by adding thereto the following chapter: |
3 | CHAPTER 106 |
4 | PUBLIC HEALTH DATA PRIVACY AND PROTECTION ACT |
5 | 23-106-1. Definitions. |
6 | For purposes of this chapter: |
7 | (1) “De-identified data” means data from which identifiers have been removed in |
8 | accordance with applicable state and federal standards such that the data cannot reasonably be used |
9 | to identify an individual. |
10 | (2) “Line-level data” means reportable disease data that includes direct or indirect |
11 | identifiers, or that can reasonably be used to identify an individual case, contact, or reporting entity. |
12 | Individual-level or line-level data can also be known as record-level data. |
13 | (3) “Public health purpose” means activities necessary to prevent or control disease, injury, |
14 | or disability including, but not limited to public health surveillance, investigation, outbreak |
15 | response, intervention, and evaluation. |
16 | (4) “Reportable disease data” means any information, record, laboratory result, medical |
17 | record, or other data collected or maintained by Rhode Island department of health (“department”) |
18 | pursuant to state law or regulation for the purpose of disease reporting, surveillance, investigation, |
| |
1 | control, or prevention. |
2 | 23-106-2. Confidentiality of reportable disease data. |
3 | (a) All reportable disease data, including line-level data, in the possession or control of the |
4 | department shall be confidential and shall not be considered a public record. |
5 | (b) Such data shall not be disclosed, subpoenaed, or otherwise released except as expressly |
6 | authorized in § 23-106-3 or as required by federal law. |
7 | (c) The confidentiality protections in this section apply regardless of the format of the data, |
8 | including paper records, electronic records, and databases. |
9 | 23-106-3. Authority and permitted releases. |
10 | (a) The Rhode Island department of health is the sole authority responsible for determining |
11 | access to, confidentiality of, and release of reportable disease data. No other state agency, political |
12 | subdivision, or entity shall release reportable disease line-level data without written authorization |
13 | by the department. |
14 | (b) The department may release de-identified reportable disease line-level data only when |
15 | necessary for a public health purpose, including: |
16 | (1) Sharing with other local, state, tribal, territorial, or federal public health authorities |
17 | (including the Centers for Disease Control and Prevention) for surveillance, investigation, or |
18 | control activities; |
19 | (2) Sharing with healthcare facilities, laboratories, or providers as needed for case |
20 | management, outbreak control, or prevention; |
21 | (3) Sharing with researchers or partners pursuant to a department-approved data use |
22 | agreement that limits use to a public health purpose and prohibits re-identification or re-disclosure; |
23 | or |
24 | (4) As otherwise required by federal law. |
25 | (c) The department may release de-identified data or aggregate statistical reports when the |
26 | department determines such release is in the public interest and does not create a reasonable risk of |
27 | re-identification. |
28 | 23-106-4. Limitations on disclosure. |
29 | (a) Line-level reportable disease data shall not be released for purposes unrelated to public |
30 | health, including litigation, commercial purposes, or general public records requests. |
31 | (b) Any recipient of line-level data must comply with department conditions for use, |
32 | security, retention, and destruction, as set forth in a department data use agreement or equivalent |
33 | written instrument. |
34 | (c) Persons authorized by the director may conduct research studies pursuant to 216 RICR |
| LC005897 - Page 2 of 4 |
1 | 30-05-1; provided, however, that the researcher shall submit a written request for information, shall |
2 | execute a research agreement that protects the confidentiality of the information provided and |
3 | obtain any relative human subjects approval. |
4 | (d) The department may enter into collaborative agreements with registries of states and |
5 | exchange individual or group information provided that maximum protections are afforded the |
6 | confidentiality of citizens of Rhode Island in accordance with state law. |
7 | (e) Immunization information, obtained pursuant to § 23-1-44, shall only be released from |
8 | the immunization registry to the following individuals and agencies, unless the registrant, or the |
9 | parent or guardian if the registrant is a minor, objects to such disclosure. All such disclosures shall |
10 | comply with the privacy protections of chapter 37.3 of title 5 and the Health Insurance Portability |
11 | and Accountability Act of 1996, Pub. L. No. 104-191 (HIPAA), as amended and all other applicable |
12 | state and federal laws: |
13 | (1) Licensed health care providers providing direct care to the registrant-patient; |
14 | (2) Elementary and secondary school nurses and institutions of higher education, and |
15 | registration officials who require proof of immunization for school enrollment and disease control; |
16 | (3) State Women Infants and Children, or WIC, nutrition program staff who administer |
17 | WIC benefits to eligible infants and children; |
18 | (4) Staff of state agencies or state programs whose duties include education and outreach |
19 | related to the improvement of immunization coverage rates; |
20 | (5) Health plans for immunization rate improvement and quality improvement efforts; and |
21 | (6) Any other entity with the express written consent of the registrant or the registrant’s |
22 | parent or guardian if the registrant is a minor. |
23 | (f) Notwithstanding the provisions of subsection (e) of this section; |
24 | (1) Persons authorized by the director may conduct research studies pursuant to § 23-1- |
25 | 18(10); provided, however, the researcher shall submit a written request for information, shall |
26 | execute a research agreement that protects the confidentiality of the information provided, and |
27 | obtain any relative human subject’s approval. |
28 | (2) The department may enter into collaborative agreements with registries of other states |
29 | and exchange individual or group information provided that maximum protections are afforded the |
30 | confidentiality of registrant information in accordance with state and federal law. |
31 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC005897 | |
======== | |
| LC005897 - Page 3 of 4 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- PUBLIC HEALTH DATA PRIVACY AND | |
PROTECTION ACT | |
*** | |
1 | Thia act would create the public health data privacy and protection act to regulate the |
2 | reporting of information relating to reportable disease data in the possession of the department of |
3 | health. |
4 | This act would take effect upon passage. |
======== | |
LC005897 | |
======== | |
| LC005897 - Page 4 of 4 |